Most Recent
Bill Papas’ girlfriend hits back at Westpac’s case over alleged $294M fraud
Bill Papas’ girlfriend Louise Agostino has hit back at Westpac’s lawsuit accusing her of involvement in the Forum Group director’s alleged $294 million fraud, denying all allegations and arguing that the bulk of the bank’s claims against her should be struck out.
‘Fugitive’ Bill Papas entitled to protect lawyer’s notes, court told
A lawyer for Forum Finance director Bill Papas has argued the alleged fraudster should be able to shield documents held by his former lawyer under a claim for legal professional privilege despite being a “fugitive” from contempt charges.
ACCC says agreement to settle Revlimid patent suit could violate cartel laws
The ACCC has refused to authorise a patent settlement and license agreement between Bristol-Myers Squibb unit Celgene and two generic drug makers who sued to invalidate the patents for its blockbuster cancer drug Revlimid, saying it could distort competition between generic drug makers.
Full Court deals drug companies a blow on patent term extensions
The Full Court has upheld two judgments that shortened patent term extensions granted to Merck Sharpe & Dohme and Ono Pharmaceuticals, finding the extension regime cannot be construed as achieving a "commercial outcome for a patentee".
Westpac stalls on extradition of Forum Finance’s Bill Papas
Westpac has yet to commence extradition proceedings against Forum Finance director Bill Papas due to concerns that the alleged fraudster may face only contempt charges if he is brought back to Australia prematurely.
ASIC drops most claims against Rio Tinto over $5.8B acquisition
The Australian Securities and Investments Commission has dropped all but one claim against Rio Tinto in a four-year-long case over disclosures related to its troubled $5.8 billion acquisition of a Mozambique coal mining business and abandoned all claims against the mining giant's former CEO and CFO.
Celgene drops patent suit against Dr Reddy’s over Revlimid generic
Bristol-Myers Squibb unit Celgene has dropped a lawsuit accusing Indian generics company Dr Reddy's Laboraties of threatening to infringe its patent for Revlimid with the planned launch of a generic version of the blockbuster cancer drug in Australia.
Jones Day recruits leading energy partner from Clayton Utz
US law firm Jones Day has nabbed leading energy and natural resources partner Dan Howard from Clayton Utz after more than 26 years with the firm.
Rio Tinto to cop penalty in ASIC case over failed $5.8B acquisition
Rio Tinto will face a penalty in proceedings brought by the Australian Securities and Investments Commission alleging the mining giant misled shareholders about the resources of a Mozambique mining company it acquired for $5.8 billion in 2011 and later offloaded for $70 million.
Forum director Tesoriero questions sale of Papas’ Sydney residence
Forum Finance director Vince Tesoriero has raised concerns about the validity of the sale of a $4 million home in Sydney inner-West suburb Rozelle where company founder Bill Papas and his girlfriend lived, but a judge has indicated any attempt to block the sale would be "hopeless".